Remote Monitoring of Treatment Response in Parkinson's Disease: The Habit of Typing on a Computer.


Journal

Movement disorders : official journal of the Movement Disorder Society
ISSN: 1531-8257
Titre abrégé: Mov Disord
Pays: United States
ID NLM: 8610688

Informations de publication

Date de publication:
10 2019
Historique:
received: 11 02 2019
revised: 03 05 2019
accepted: 13 05 2019
pubmed: 19 6 2019
medline: 13 6 2020
entrez: 19 6 2019
Statut: ppublish

Résumé

The recent advances in technology are opening a new opportunity to remotely evaluate motor features in people with Parkinson's disease (PD). We hypothesized that typing on an electronic device, a habitual behavior facilitated by the nigrostriatal dopaminergic pathway, could allow for objectively and nonobtrusively monitoring parkinsonian features and response to medication in an at-home setting. We enrolled 31 participants recently diagnosed with PD who were due to start dopaminergic treatment and 30 age-matched controls. We remotely monitored their typing pattern during a 6-month (24 weeks) follow-up period before and while dopaminergic medications were being titrated. The typing data were used to develop a novel algorithm based on recursive neural networks and detect participants' responses to medication. The latter were defined by the Unified Parkinson's Disease Rating Scale-III (UPDRS-III) minimal clinically important difference. Furthermore, we tested the accuracy of the algorithm to predict the final response to medication as early as 21 weeks prior to the final 6-month clinical outcome. The score on the novel algorithm based on recursive neural networks had an overall moderate kappa agreement and fair area under the receiver operating characteristic (ROC) curve with the time-coincident UPDRS-III minimal clinically important difference. The participants classified as responders at the final visit (based on the UPDRS-III minimal clinically important difference) had higher scores on the novel algorithm based on recursive neural networks when compared with the participants with stable UPDRS-III, from the third week of the study onward. This preliminary study suggests that remotely gathered unsupervised typing data allows for the accurate detection and prediction of drug response in PD. © 2019 International Parkinson and Movement Disorder Society.

Identifiants

pubmed: 31211469
doi: 10.1002/mds.27772
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1488-1495

Informations de copyright

© 2019 International Parkinson and Movement Disorder Society.

Références

Fahn S, Elton R. Unified Parkinson's Disease Rating Scale (UPDRS). In: Fahn S, Marsden CD, Calne DB, et al., eds. Recent Developments in Parkinson's Disease, Vol 2. Florham Park, NJ: Macmillan Health Care Information, 1987:153-163.
Kieburtz K, Olanow CW. Advances in clinical trials for movement disorders. Mov Disord 2015;30:1580-1587. https://doi.org/10.1002/mds.26371
Schneider SA, Drude L, Kasten M, et al. A study of subtle motor signs in early Parkinson's disease. Mov Disord 2012;27:1563-1566. https://doi.org/10.1002/mds.25161
Maetzler W, Domingos J, Srulijes K, et al. Quantitative wearable sensors for objective assessment of Parkinson's disease. Mov Disord 2013;28:1628-1637. https://doi.org/10.1002/mds.25628
Sánchez-Ferro Á, Elshehabi M, Godinho C, et al. New methods for the assessment of Parkinson's disease (2005 to 2015): a systematic review. Mov Disord 2016;31:1283-1292. https://doi.org/10.1002/mds.26723
Ferreira JJ, Godinho C, Santos AT, et al. Quantitative home-based assessment of Parkinson's symptoms: the SENSE-PARK feasibility and usability study. BMC Neurol 2015;15:89. https://doi.org/10.1186/s12883-015-0343-z
Redgrave P, Rodriguez M, Smith Y, et al. Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease. Nat Rev Neurosci 2010;11:760-772. https://doi.org/10.1038/nrn2915
Catalan MJ, Ishii K, Honda M, et al. A PET study of sequential finger movements of varying length in patients with Parkinson's disease. Brain 1999;122 ( Pt 3:483-495. https://doi.org/10.1093/brain/122.3.483
Lehéricy S, Bardinet E, Tremblay L, et al. Motor control in basal ganglia circuits using fMRI and brain atlas approaches. Cereb Cortex 2006;16:149-161. https://doi.org/10.1093/cercor/bhi089
Giovannoni G, van Schalkwyk J, Fritz VU, et al. Bradykinesia akinesia inco-ordination test (BRAIN TEST): an objective computerised assessment of upper limb motor function. J Neurol Neurosurg Psychiatry 1999;67:624-629. https://doi.org/10.1136/jnnp.67.5.624
Hasan H, Athauda DS, Foltynie T, et al. Technologies assessing limb bradykinesia in Parkinson's disease. J Parkinsons Dis 2017;7:65-77. https://doi.org/10.3233/JPD-160878
Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 2008;23:2129-2170. https://doi.org/10.1002/mds.22340
Giancardo L, Sánchez-Ferro Á, Arroyo-Gallego T, et al. Computer keyboard interaction as an indicator of early Parkinson's disease. Sci Rep 2016;6:34468. https://doi.org/10.1038/srep34468
Arroyo-Gallego T, Ledesma-Carbayo MJ, Butterworth I, et al. Detecting motor impairment in early Parkinson's disease via natural typing interaction with keyboards: validation of the neuroQWERTY approach in an uncontrolled at-home setting. J Med Internet Res 2018;20:e89. https://doi.org/10.2196/jmir.9462
Arroyo-Gallego T, Ledesma-Carbayo MJ, Sanchez-Ferro A, et al. Detection of motor impairment in Parkinson's disease via mobile touchscreen typing. IEEE Trans Biomed Eng 2017;64:1994-2002. https://doi.org/10.1109/TBME.2017.2664802
Schrag A, Sampaio C, Counsell N, et al. Minimal clinically important change on the Unified Parkinson's Disease Rating Scale. Mov Disord 2006;21:1200-1207. https://doi.org/10.1002/mds.20914
Jankovic J, Watts RL, Martin W, et al. Transdermal rotigotine: double-blind, placebo-controlled trial in Parkinson disease. Arch Neurol 2007;64:676-682. https://doi.org/10.1001/archneur.64.5.676
Poewe W, Rascol O, Barone P, et al. Extended-release pramipexole in early Parkinson disease: a 33-week randomized controlled trial. Neurology 2011;77:759-766. https://doi.org/10.1212/WNL.0b013e31822affb0
Kieburtz K, Parkinson Study Group PramiBID Investigators. Twice-daily, low-dose pramipexole in early Parkinson's disease: a randomized, placebo-controlled trial. Mov Disord 2011;26:37-44. https://doi.org/10.1002/mds.23396
Olanow CW, Rascol O, Hauser RA, et al. A double-blind, delayed-start trial of rasagiline in Parkinson's disease. N Engl J Med 2009;361:1268-1278. https://doi.org/10.1056/NEJMoa0809335
Sánchez-Ferro Á, Matarazzo M, Martínez-Martín P, et al. Minimal clinically important difference for UPDRS-III in daily practice. Mov Disord Clin Pract 2018;5:448-450. https://doi.org/10.1002/mdc3.12632
Giancardo L, Sánchez-Ferro A, Butterworth I, et al. Psychomotor impairment detection via finger interactions with a computer keyboard during natural typing. Sci Rep 2015;5:1-8. https://doi.org/10.1038/srep09678
LeCun Y, Bengio Y, Hinton G. Deep learning. Nature 2015;521:436-444. https://doi.org/10.1038/nature14539
Wissler C. The Spearman correlation formula. Science 1905;22:309-311. https://doi.org/10.1126/science.22.558.309
Spearman C. The proof and measurement of association between two things. By C. Spearman, 1904. Am J Psychol 2012;100:441-471.
Litvan I, Goldman JG, Tröster AI, et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord 2012;27:349-356. https://doi.org/10.1002/mds.24893
Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377-381. https://doi.org/10.1016/j.jbi.2008.08.010
van Rossum G, de Boer J. Interactively testing remote servers using the Python programming language. CWI Q 1991;4:283-303.
R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2016.
Stebbins GT, Goetz CG, Burn DJ, et al. How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the Unified Parkinson's Disease Rating Scale. Mov Disord 2013;28:668-670. https://doi.org/10.1002/mds.25383
Taylor Tavares AL, Jefferis GSXE, Koop M, et al. Quantitative measurements of alternating finger tapping in Parkinson's disease correlate with UPDRS motor disability and reveal the improvement in fine motor control from medication and deep brain stimulation. Mov Disord 2005;20:1286-1298. https://doi.org/10.1002/mds.20556
Noyce AJ, Nagy A, Acharya S, et al. Bradykinesia-akinesia incoordination test: validating an online keyboard test of upper limb function. PLoS ONE 2014;9:e96260. https://doi.org/10.1371/journal.pone.0096260
Bishop CM. Pattern Recognition and Machine Learning. 1st ed. New York, NY: Springer, 2006.

Auteurs

Michele Matarazzo (M)

HM-CINAC, Hospital Universitario HM Puerta del Sur, Móstoles and Medical School, CEU-San Pablo University, Madrid, Spain.
Neurology Department, Instituto de Investigación del Hospital 12 de Octubre, Madrid, Spain.
Centro de Investigación Biomédica en Red, Enfermedades Neurodegenerativas, Madrid, Spain.
Pacific Parkinson's Research Centre, University of British Columbia, Vancouver, British Columbia, Canada.

Teresa Arroyo-Gallego (T)

Biomedical Image Technologies, Universidad Politécnica de Madrid and CIBERBBN, Madrid, Spain.
Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
nQ Medical Inc., Cambridge, Massachusetts, USA.

Paloma Montero (P)

Neurology Department, Instituto de Investigación del Hospital 12 de Octubre, Madrid, Spain.
Movement Disorders Unit, Hospital Clínico San Carlos, Madrid, Spain.

Verónica Puertas-Martín (V)

Neurology Department, Instituto de Investigación del Hospital 12 de Octubre, Madrid, Spain.

Ian Butterworth (I)

Research Laboratory of Electronics, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.

Carlos S Mendoza (CS)

Research Laboratory of Electronics, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.

María J Ledesma-Carbayo (MJ)

Biomedical Image Technologies, Universidad Politécnica de Madrid and CIBERBBN, Madrid, Spain.

María José Catalán (MJ)

Movement Disorders Unit, Hospital Clínico San Carlos, Madrid, Spain.

José Antonio Molina (JA)

Neurology Department, Instituto de Investigación del Hospital 12 de Octubre, Madrid, Spain.

Félix Bermejo-Pareja (F)

Neurology Department, Instituto de Investigación del Hospital 12 de Octubre, Madrid, Spain.

Juan Carlos Martínez-Castrillo (JC)

Movement Disorders Unit, Hospital Ramón y Cajal, Madrid, Spain.

Lydia López-Manzanares (L)

Movement Disorders Unit, Hospital de la Princesa, Madrid, Spain.

Araceli Alonso-Cánovas (A)

Movement Disorders Unit, Hospital Ramón y Cajal, Madrid, Spain.

Jaime Herreros Rodríguez (JH)

Neurology Department, Hospital Infanta Leonor, Madrid, Spain.

Ignacio Obeso (I)

HM-CINAC, Hospital Universitario HM Puerta del Sur, Móstoles and Medical School, CEU-San Pablo University, Madrid, Spain.
Centro de Investigación Biomédica en Red, Enfermedades Neurodegenerativas, Madrid, Spain.

Pablo Martínez-Martín (P)

Centro de Investigación Biomédica en Red, Enfermedades Neurodegenerativas, Madrid, Spain.
Area of Applied Epidemiology, National Centre of Epidemiology, Carlos III Institute of Health, Madrid, Spain.

José Carlos Martínez-Ávila (JC)

Clinical Research Unit, Instituto de Investigación Hospital 12 de Octubre, Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública, Hospital Universitario 12 de Octubre, Madrid, Spain.

Agustín Gómez de la Cámara (AG)

Clinical Research Unit, Instituto de Investigación Hospital 12 de Octubre, Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública, Hospital Universitario 12 de Octubre, Madrid, Spain.

Martha Gray (M)

Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Research Laboratory of Electronics, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.

José A Obeso (JA)

HM-CINAC, Hospital Universitario HM Puerta del Sur, Móstoles and Medical School, CEU-San Pablo University, Madrid, Spain.
Centro de Investigación Biomédica en Red, Enfermedades Neurodegenerativas, Madrid, Spain.

Luca Giancardo (L)

Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Center for Precision Health, School of Biomedical Informatics, University of Texas Health Science Center at Houston, Houston, Texas, USA.

Álvaro Sánchez-Ferro (Á)

HM-CINAC, Hospital Universitario HM Puerta del Sur, Móstoles and Medical School, CEU-San Pablo University, Madrid, Spain.
Neurology Department, Instituto de Investigación del Hospital 12 de Octubre, Madrid, Spain.
Centro de Investigación Biomédica en Red, Enfermedades Neurodegenerativas, Madrid, Spain.
Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH